These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6303239)

  • 1. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
    Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
    Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
    Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
    N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF; Grom E; Jähnchen E; Roskamm H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
    Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
    Volpini M; Gargano M; Cuccia C; Dei Cas L; Gei P; Metra M; Moretti R; Riva S
    Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
    Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
    J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
    Charbonnier B; Monpère C; Desveaux B; Cosnay P; Fauchier JP; Brochier M
    Ann Cardiol Angeiol (Paris); 1984; 33(4):233-7. PubMed ID: 6087714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Captopril therapy in chronic congestive heart failure].
    Morgera T; Humar F; Mestroni L; Maras P; Camerini F
    G Ital Cardiol; 1983; 13(1):39-46. PubMed ID: 6347789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of captopril in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Nicolin M; Streian C
    Med Interne; 1989; 27(2):99-105. PubMed ID: 2683008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does captopril decrease endothelial production of endothelin?].
    Mazurek W; Halawa B
    Pol Merkur Lekarski; 1997 Sep; 3(15):105-8. PubMed ID: 9461703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
    Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.